Simplyhealth invests in tele-eyecare startup

Health provider Simplyhealth has invested a majority stake in eyecare startup OcuPlan, which allows personalised management for patients.

The company said that the deal will enable expansion into innovative treatment and funding for conditions such as glaucoma, ocular hypertension, age-related macular degeneration and diabetic retinopathy.

This is in alignment with aims to reduce strain on NHS services and allow affordable healthcare for all.

Dr Sneh Khemka, CEO of Simplyhealth, said: ‘As a former ophthalmic surgeon myself, I know that OcuPlan’s technology can empower people with long-term eye conditions to take control of their treatment and their health. It can also really help to take the strain off the NHS, and I couldn’t be prouder to make OcuPlan our first investment as CEO.’